Coronavirus: GK, General Studies and Current Affairs

‘Covishield’ Vaccine to Start Trials in India

The Serum Institute of India is going to launch its first COVID 19 vaccine candidate for trials very soon in India. The vaccine has been named as ‘Covishield’. It has been developed by the Oxford University and pharmaceutical giant, AstraZeneca. The Serum Institute is going to apply for the license for trials of the vaccine ..

UK to Introduce New COVID 19 Antibody Test

United Kingdom has conducted secret human trials for its COVID 19 antibody test and the results have shown 98.6% accuracy for the test. That is why the British Ministers have now decided to distribute millions of such tests free of cost to the citizens. Highlights Known as the fingerprick tests, the UK antibody test will ..

Two Vaccines in India to start clinical trial for COVID-19: ICMR

The Indian Council of Medical Research (ICMR) has stated that two vaccines developed in India are going to undergo trial from July 2020. The organization has decided to rope in 1000 volunteers for this purpose, at the earliest. These vaccines have already undergone animal trials and have shown successful results. The vaccines have been developed ..

DCGI approves Favipiravir for treating COVID-19

The drugs controller general of India (DGCI) granted approval to Glenmark Pharmaceuticals to manufacture and market oral antiviral drug Favipiravir to treat mild and moderate COVID-19 cases in India. The drug will be marketed under the brand name ‘FabiFlu’. It is known to prevent the virus from replication. In Japan, the drug is sold under ..

Brazil’s COVID-19 cases crosses 1 million mark

On 19th June, Brazil has confirmed that the country’s COVID-19 cases have surpassed 1 million, second only to the United States. Brazilian President Jair Bolsonaro is still downplaying the risks of the on-going pandemic despite facing nearly 50,000 deaths from COVID-19 in last 3 months, saying that the impact of lockdown on the country’s economy ..